longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

IQVIA

IQV

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 31.34, above the reasonable range, cheaper than 19.67% of the time in the past 3 years, and the industry ranks 6/59, the industry Median -1.56.

31.34xP/E
$261.77Stock price
$8.35Earnings per share
31.34xP/E
Stock price$261.77Earnings per share$8.35

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
28.14x
Typical range
21.87x–31.31x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
09182736

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific
32.36x13.43%$225.48B
DHRUSDanaher
35.14x17.40%$140.70B
IQVUSIQVIA
31.34x0.96%$43.09B
AUSAgilent Tech
28.77x12.34%$41.42B
ILMNUSIllumina
37.83x9.25%$31.17B
MTDUSMettler Toledo
28.62x10.40%$25.92B
WXXWYUSWuXi Biologics
34.22x--$24.64B
MEDPUSMedpace
33.36x15.09%$16.40B
QGENUSQiagen NV
21.44x0.70%$8.78B
STVNUSStevanato Group SpA
36.53x8.92%$5.71B
SHCUSSotera Health
32.07x154.32%$5.24B
BLFSUSBioLife Solutions
29.48x1,266.67%$1.71B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.